Stock Loser of the Day!

[thegreatgate]

The Biggest Loser........

At the following link you'll find the stocks that have dropped the most by percentage on the day. A lot of times these things build negative momentum and drop like rocks....The panic and fear sellers pull the trigger and bring these babies down, at times, -50% or more for the day. If the news isn't all that bad they usually go up a good 30% from the day low. Here's where you can find some of the biggest losers out there:
Yahoo Finance Biggest Losers by Percentage

Current loser: UCBH at $1.44 (-31.10%)

[Volatile22]

Nice thread! I'd like to contribute

Courtesy of Aufan Markets at a Glance

He hooked me up with that link the other day.

[thegreatgate]

04/24/2009

BLOOD, I mean BLUD might be a good one. Current PPS is $15.10 (down 28.03%).

Never seen RSI readings that close to 0 ... RSI (5) is at 4.29 on a scale of 0 to 100 where 30 is supposed to represent oversold. However, they did get a....

subpoena from the United States Department of Justice, Antitrust Division, requesting documents for the period beginning Sept. 1, 2000 through the present, pertaining to an investigation of possible violations of the federal criminal antitrust laws in the blood reagents industry. Immucor intends to fully cooperate with the investigation.

About BLUD:

Immucor, Inc. (Immucor) develops, manufactures and sells a complete line of reagents and automated systems used primarily by hospitals, clinical laboratories and blood banks in a number of tests performed to detect and identify certain properties of the cell and serum components of human blood prior to blood transfusion. During the fiscal year ended May 31, 2008 (fiscal 2008), the Company launched the Echo instrument. The Echo has many of the features of the Galileo, the Company’s automated assay instrument which caters to customers, including a test menu. As of May 31, 2008, the Company had received orders for a total of 257 Echo instruments worldwide, including 56 in Europe, 196 in North America and five in Japan, and approximately 91 of these Echo instruments were generating reagent revenues. In August 2008, the Company closed its acquisition of BioArray Solutions Ltd.

If they can clear their name this will skyrocket, chart:

[Volatile22]

holy chart! that is ugly lol. Definitely a good one for this thread. RSI is ridiculous. Im gonna go check it out. If anything throw a few hundred at it and see what happens.

[Volatile22]

Figured id give it a shot. Hopped in for a small position. Lets see if they can recover.

[Volatile22]

Not a bad play. Made about 1$ per share today. Ended up selling it off for another play, but all in all made some nice green off the bounce today.

[thegreatgate]

SSW---dropping like a rock....$7.68/share (down 28.89% or $3.12/share)

* Q1 profit $0.31/shr vs yr-ago loss $0.65/shr

* Q1 revenue up 16 percent

* Slashes dividend by 79% to fund new building program

* Shares down 36 pct in trading before the bell

SSW: Summary for SEASPAN CORPORATION - Yahoo! Finance

[thegreatgate]

Originally Posted by thegreatgate

SSW---dropping like a rock....$7.68/share (down 28.89% or $3.12/share)

* Q1 profit $0.31/shr vs yr-ago loss $0.65/shr

* Q1 revenue up 16 percent

* Slashes dividend by 79% to fund new building program

* Shares down 36 pct in trading before the bell

SSW: Summary for SEASPAN CORPORATION - Yahoo! Finance

SSW at lod at $6.69/share.......this is worth keeping an eye on for the next 2 days in my opinion....panic sellers are overreacting as usual...

[Volatile22]

wow the company has a profit and it gets punished! The divi slash is prob what took her down, but man flags are definitely flying right now. For sure one to watch as I would suspect a nice bounce off such a beating for really no reason.

Nice find GG.

[Volatile22]

OK might have some potential in one of our very own. Guys check out ACAS. It missed its earnings by .06 and is down big today (38% as of now). S&P maintains its hold recommendation.

Some news that came along with the earnings yesterday:

American Capital Ltd. (Nasdaq: ACAS) announced that on May 1 it completed the sale of its portfolio company Piper Aircraft Inc. ("Piper") to Imprimis. American Capital realized a gain of $31 million from the transaction, subject to post closing adjustments. American Capital's total inception to date realized gains on its Piper investments were $48 million and its compounded annual rate of return, including interest and fees earned over the life of its investment was 19%. Including investments in Piper by American Capital's affiliated funds under management, the inception to date realized gains were $51 million and the compounded annual rate of return was 18%.

Including the sale, American Capital received 4.5 times its equity and subordinated debt investments. The proceeds received by American Capital were greater than the fourth quarter 2008 valuation of the investment by $7.7 million, or 33%.

American Capital first invested $20 million in subordinated debt in Piper in May 1998. In June 2003, American Capital invested a subsequent $34 million in the buyout and recapitalization of Piper. American Capital's 2003 investment took the form of senior debt and a revolving credit facility. For more information about American Capital's investment in Piper, please go to American Capital - - Piper Aircraft, Inc..

"With this sale of Piper, American Capital is exiting one of its first investments with an excellent outcome. Our investment in Piper is an outstanding example of American Capital's long term commitment to portfolio companies and their management teams as well as our value creation capabilities," said Gordon O'Brien, President, Specialty Finance and Operations. "Following our initial investment in Piper in 1998 and then our buyout in 2003, we have worked closely with Piper's management team, which has done a tremendous job growing an iconic brand in the aviation industry through product innovations, quality manufacturing and a dedicated workforce. We are proud to have been a part of Piper's growth and success story."

Piper is a leading manufacturer of general aviation aircraft. Based in Vero Beach, Florida, the company designs, develops and produces new aircraft and proprietary replacement and remanufactured spare parts, and is the only general aviation manufacturer to offer a comprehensive line of aircraft, from trainers and high-performance piston aircraft for personal and business use to turbine-powered business aircraft.

"We are extremely delighted with the impressive results of our sale of Piper. The sale of Piper during such challenging economic times demonstrates that the market is still receptive to the acquisition of strong assets," said Steve Price, Managing Director, Operations Team. "We are excited for Piper as it moves forward with new ownership under Imprimis and expands in new geographic markets, especially Asia, with its comprehensive product line."

Since American Capital's August 1997 IPO through the fourth quarter of 2008, the company has earned a 17% compounded annual return, including interest, dividends, fees and net gains, on 249 realizations of senior debt, subordinated debt and equity investments, totaling $11 billion of committed capital. These realizations represent 47% of all amounts invested by American Capital since its August 1997 IPO. Proceeds from these realizations exceeded the total associated prior quarter valuation of the investments by less than 1%. American Capital earned a 30% compounded annual return on the exit of its equity investments, including dividends, fees and net gains.